SpringerProtocols: Abstract: Structure and Properties of Human Immunoglobulin Light-Chain Dimers

Structure and Properties of Human Immunoglobulin Light-Chain Dimers

By: Fred J. Stevens², Marianne Schiffer²

Abstract

Full Text

Download PDF (2366K)

Antibodies are multisubunit proteins, but unlike many other multisubunit proteins, it is possible to study structural and functional properties of an antibody subunit free of the others. Thus, antibodies are singular proteins in that they are highly amenable to analysis by a fundamental scientific research strategy, i.e., investigation of complex systems by study of its parts. The metabolism of even a superficially simple bacterial cell cannot be understood without a rigorous understanding of the kinetic properties of each of the enzymes involved. In much the same way, the quaternary interactions of protein subunits cannot be understood except in those relatively rare cases in which the subunit and individual domain components of a complex protein can be examined individually, yielding structural and biophysical information.

Affiliation(s): (2) Center for Mechanistic Biology and Biotechnology, Argonne National Laboratory, Argonne, IL

Book Title: Antibody Engineering Protocols

Series: Methods in Molecular Biology | Volume: 51 | Pub. Date: Jul-13-1995 | Page Range: 51-81 | DOI: 10.1385/0-89603-275-2:51

Subject: Immunology

References

Download References

1.	Stevens, F. J., Solomon, A., and Schiffer, M. (1991) Bence Jones proteins: a powerful tool for the fundamental study of protein chemistry and pathophysiology. Biochemistry 30, 6803–6805.

2.	Solomon, A. (1982) Bence Jones proteins: malignant or benign? New Engl. J. Med. 306, 605–607.

3.	Castano, E. and Frangione, B. (1988) Biology of disease: human amyloidosis, Alzheimer’s disease and related disorders. Lab. Invest. 58, 122–132.

4.	Feiner, H. (1988) Pathology of dysproteinemia: light chain amyloidosis, non-amyloid immunoglobulin deposition disease, cryoglobulinemia syndromes, and macroglobulinemia of Waldenstrom. Human Pathol. 19, 1255–1272.

5.	Solomon, A. and Weiss, D. T. (1988) A perspective of plasma cell dyscrasias: clinical implications of monoclonal light chains in renal disease, in The Kidney in Plasma Cell Dyscrasias (Minetti, L., D’Amico, G., and Ponticelli, C., eds.), Kluwer Academic Publishers, Dordrecht, pp. 3–18.

6.	Orfila, C., Leper, J.-C., Modesto, A., Bernadet, P., and Suc, J.-M. (1991) Fanconi’s syndrom, kappa light-chain myeloma, non-amyloid fibrils and cytoplasmic crystals in renal tubular epithelium. Am. J. Nephrol. 11, 345–349.

7.	Solomon, A. and Weiss, D. T. (1993) Ominous consequences of immunoglobulin deposition. New Engl. J. Med. 329, 1422–1423.

8.	Padlan, E. A. (1994) Anatomy of the antibody molecule. Mol Immunol. 31, 169–217.

9.	Fan, Z.-C., Shan, L., Guddat, L. W., He, Z.-M., Gray, W. R., Raison, R. L., and Edmundson, A. B. (1992) Three-dimensional structure of an Fv from a human IgM immunoglobulin. J. Mol. Biol. 228, 188–207.

10.	Chang, C.-H, Short, M. T., Westholm, F. A., Stevens, F. J., Wang, B.-C., Furey, W., Solomon, A., and Schiffer, M. (1985) Novel arrangement of immunoglobulin variable domains: X-ray crystallographic analysis of the lambda-chain dimer Bence Jones protein Loc. Biochemistry 24, 4890–4897.

11.	Schiffer, M., Ainsworth, C., Xu, Z.-B., Carperos, W., Olsen, K., Solomon, A., Stevens, F. J., and Chang, C.-H. (1989) Structure of a second crystal form of Bence Jones protein Loc: strikingly different domain associations in two crystal forms of a single protein. Biochemistry 28, 4066–4072.

12.	Furey, W., Wang, B. C., Yoo, C. S., and Sax, M. (1983) Structure of a novel Bence Jones protein (Rhe) fragment at 1.6 Å resolution. J. Mol. Biol. 167, 661–692.

13.	Xu, Z.-B. and Schiffer, M. (1988) The refinement and structure of Mcg Bence Jones dimer at 2.3 Å resolution. Ann. Mtg. Amer. Crystal. Assoc. PD28.

14.	Ely, K. R., Herron, J. N., Harker, M., and Edmundson, A. B. (1989) Three-dimensional structure of a light chain dimer crystallized in water: conformational flexibility of a molecule in two crystal forms. J. Mol. Biol. 210, 601–615.

15.	Ely, K. R., Herron, J. N., and Edmundson, A. B. (1990) Three-dimensional structure of a hybrid light chain dimer: protein engineering of a binding cavity. Mol. Immunol. 27, 101–114.

16.	Fehlhammer H., Schiffer, M., Epp, O., Colman, P. M., Lattman, E. E., Schwager, P., Steigemann, W. S., and Schramm, H. J. (1975) The structure determination of the variable portion of the Bence Jones protein Au. Biophys. Struct. Mechanism 1, 139–146.

17.	Epp, O., Lattman, E., Schiffer, M., Huber, R., and Palm, W. (1975) The molecular structure of a dimer composed of the variable portions of the Bence Jones protein Rei refined at 2.0 Å resolution. Biochemistry 14, 4943–4952.

18.	Colman, P., Schramm, H., and Guss, J. (1977) Crystal and molecular structure of the dimer of variable domains of the Bence Jones protein Roy. J. Mol. Biol. 116, 73–79.

19.	Schiffer, M., Girling, R., Ely, K. R., and Edmundson, A. B. (1973) Structure of a lambda-type Bence Jones protein at 3.5 Å resolution. Biochemistry 12, 4620–4631.

20.	Poljak, R. J., Amzel, L. M., Avey, H. P., Chen, B. L., Phizackerley, R. P., and Saul, F. (1973) Three-dimensional structure of the Fab′ fragment of a human immunoglobulin at 2.8 Å resolution. Proc. Natl. Acad. Sci. USA 70, 3305–3310.

21.	Segal, D. M., Padlan, E. A., Cohen, G. H., Rudikoff, S., Potter, M., and Davies, D. R. (1974) The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc. Natl. Acad. Sci. USA 71, 4298–4302.

22.	Wu, T. T. and Kabat, E. A. (1972) An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 132, 211–250.

23.	Edmundson, A. B., Ely, K. R., Abola, E. E., Schiffer, M., and Panagiotopoulos, N. (1975) Rotational allomerism and divergent evolution of domains in immunoglobulin light chains. Biochemistry 14, 3953–3961.

24.	Schiffer, M., Stevens, F. J., Westholm, F. A., Carlson, D., and Schoenborn, B. (1982) Small angle neutron scattering study of Bence Jones protein Mcg: comparison of structures in solution and in crystal. Biochemistry 21, 2874–2878.

25.	Schiffer, M., Westholm, F. A., Panagiotopoulos, N., and Solomon, A. (1978) Crystallographic data on a complete κ-type human Bence Jones protein. J. Mol. Biol 124, 287–290.

25a.	Huang, D.-B., Chang, C.-H., Ainsworth, C., Brunger, A. T., Eulite, M., Solomon, A., Stevens, F. J., Schiffer, M. (1994) Comparison of crystal structures of two homologous proteins: structural origin of altered domain interactions in immunoglobulin light-chain dimers. Biochemistry 33, 14,848–14,857.

26.	Klein, R., Jaenichen, R., and Zachau, H. G. (1993) Expressed human immunoglobulin κ genes and their hypermutation. Eur. J. Immunol. 23, 3248–3271.

27.	Rocca, A., Khamlichi, A. A., Aucouturier, P., Noel, L.-H., Denoryoy, L., and Preud’homme, J. L. (1993) Primary structure of a variable region of the VkI subgroup (ISE) in light chain deposition disease. Clin. Exp. Immunol. 91, 506–509.

28.	Cogne, M., Preud’homme, J.-L, Bauwens, M., Touchard, G., and Aucouturier, P. (1991) Structure of a monoclonal kappa chain of the V-kappa-IV subgroup in the kidney and plasma cells in light chain deposition disease. J. Clin Invest. 87, 2188–2190.

29.	Liepnieks, J. J., Dwulet, F. E., and Benson, M. D. (1990) Amino acid sequence of a kappa I primary (AL) amyloid protein (AND). Mol. Immunol. 27, 481–485.

30.	Hurle, M. R., Helms, L., Li, L., Chan, W., and Wetzel, R. (1994) A role for destabilizing amino acid replacements in light chain amyloidosis. Proc. Natl. Acad. Sci. USA 91, 5446–5450.

31.	Ch’ang, L.-Y., Yen, C.-P., Besl, L., Schell, M., and Solomon, A. (1994) Identification and characterization of a functional human Igλ_VI germline gene. Mol. Immunol. 31, 531–536.

32.	Reidl, L. S., Kinoshita, C. M., and Steiner, L. A. (1992) Wild mice express an Ig V-lambda gene that differs from any V-lambda in BALB/c but resembles a human V-lambda subgroup. J. Immunol. 149, 471–480.

33.	Chuchana, P., Blancher, A., Brockly, F., Alexandre, D., Leranc, G., and Lefranc, M.-P. (1989) Definition of the human immunoglobulin variable lambda (IGLV) gene subgroups. Eur. J. Immunol. 20, 1317–1325.

34.	Edelman, G. M. and Gally, J. A. (1962) The nature of Bence Jones proteins: chemical similarities to polypeptide chains of myeloma globulins and normal gamma-globulins. J. Exp. Med. 116, 207–227.

35.	Green, R. W. (1973) Conformation and association of the light chain from a homogeneous human immunoglobulin. Biochemistry 12, 3225–3231.

36.	Azuma, T., Hamaguchi, K., and Migita, S. (1974) Interactions between immunoglobulin polypeptide chains. J. Biochem. 76, 685–693.

37.	Maeda, H., Engel, J., and Schramm, H. J. (1976) Kinetics of dimerization of the variable fragment of the Bence Jones protein Au. Eur. J. Biochem. 69, 133–139.

38.	Stevens, F. Westholm, J., F., Solomon, A., and Schiffer, M. (1980) Self-association of human immunoglobulin κI light chains: role of the third hypervariable region. Proc. Natl. Acad. Sci USA 77, 1144–1148.

39.	Stevens, F. J. and Schiffer, M. (1981) Computer simulation of protein self-association during small-zone gel filtration: estimation of equilibrium constants. Biochem. J. 195, 213–219.

40.	Kolmar, H., Frisch, C., Kleemann, G., Gotze, K., Stevens, F. J., and Fritz, H.-J. (1994) Dimerization of Bence Jones proteins: linking the rate of transcription from an Escherichia coli promoter to the association constant of REIv. Biol. Chem. Hoppe-Seyler 375, 61–70.

41.	Dorrington, K. J. (1978) The structural basis for the functional versatility of immunoglobulin G. Can. J. Biochem. 56, 1087–1101.

42.	Schiffer, M., Chang, C.-H., Naik, V. M., and Stevens, F. J. (1988) Analysis of immunoglobulin domain interactions: evidence for a dominant role of salt bridges. J. Mol. Biol. 203, 799–802.

43.	Jones, H. B. (1848) On a new substance occurring in the urine of a patient with mollities ossium. Phil. Trans. R. Soc. Lond. 55–62.

44.	Neet, K. and Putnam, F. W. (1966) Characterization of the thermal denaturation of Bence Jones proteins by ultracentrifugation at elevated temperatures. J. Biol Chem. 241, 2320–2325.

45.	Stone, M. J. (1990) Amyloidosis: a final common pathway for protein deposition in tissues. Blood 75, 531–545.

46.	Myatt E., Westholm, F. A., Weiss, D. T., Solomon, A., Schiffer, M., and Stevens, F. J. (1994) Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ deposition. Proc. Natl. Acad. Sci. USA 91, 3034–3038.

47.	Solomon, A., Weiss, D. T., and Kattine, A. (1991) Nephropathological potential of human Bence Jones proteins: experimental and clinical correlates. N. Engl. J. Med. 324, 1845–1851.

48.	Abrahamson, M. and Grubb, A. (1994) Increased body temperature accelerates aggregation of the Leu-68 Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy. Proc. Natl. Acad. Sci. USA 91, 1416–1420.

49.	Stevens, F. J., Chang, C.-H., and Schiffer, M. (1988) Dual conformations of an immunogloublin light-chain dimer: heterogeneity of antigen specificity and idiotope profile may result from multiple variable-domain interaction mechanisms. Proc. Natl. Acad. Sci. USA 85, 6895–6899.

49a.	Foote, J. and Molstein, C. (1994) Conformational isomerism and the diversity of antibodies. Proc. Natl. Acad Sci. USA 91, 10,370–10,374.

50.	Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., and Winter, G. (1986) Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321, 522–525.

51.	Riechmann, L., Clark, M., Waldmann, H., and Winter, G. (1988) Reshaping human antibodies for therapy. Nature 332, 323–327.

52.	Foote, J. and Winter, G. (1992) Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol. 224, 487–499.

53.	Kabat, E. A., Wu, T. T., Perry, H. M., Gottesman, K. S., and Foeller, C. (1991) Sequences of Proteins of Immunological Interest, 5th ed., Public Health Service National Institutes of Health, Washington, DC.

Comments (Loading...)

Post comment/View all comments